ETHYL 2-(4-AMINOPHENOXY)-2-METHYLPROPANOATE, 95.0%, 250mg

(R)-4-Phenyl-2-(6-phenylpyridin-2-yl)-4,5-dihydrooxazole, 98%, 100mg

3,6,9,12-Tetraoxatetradecan-1-ol, 95%+, 1g

2,3-Dichloro-5-methoxypyridine, 95.0%, 250mg

5-(2-Methylbenzoyl)-2-methylpyridine, 97.0%, 1g

Fmoc-N-Me-Glu-(OtBu)-OH, 95%, 25g

2,5-Dichloro-4-nitrophenol, 95.0%, 10g

2-Pyrimidinamine, 4-(3,4-dihydro-1-methyl-2(1H)-isoquinolinyl)-N-(4-fluorophenyl)-5,6-dimethyl-, hydrochloride (1:1), 25g

(E)-3-(3,5-DIFLUORO-4-((1R,3R)-2-(2-FLUORO-2-METHYLPROPYL)-3-METHYL-2,3,4,9-TETRAHYDRO-1H-PYRIDO[3,4-B]INDOL-1-YL)PHENYL)ACRYLIC ACID, 95%, 250mg

N-Benzyl-N,N-diethylethanaminium iodide, 95.0%, 25g

Tetrahydrothiophene>99.0%(GC)500mL

Fmoc-Gly-Pro-OH, 98.0%, 250mg

2-((2S,5S)-5-methyl-3,6-dioxopiperazin-2-yl)acetic acid, 95.0%, 250mg